chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.42
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: After the vaccine, patient had fever, irritability, and pain at the site of injection for 3 days. The fever resolved but the irritability has persisted (today is 6 days out from the vaccine). Mother reports that she is "not the same baby" and does not want to play as much and is less interested in eating (urine output at baseline). Her exam was unremarkable - no evidence of AOM or respiratory symptoms. No erythema, edema, or tenderness at the site of injection. Normal gait. She cried during the exam but was otherwise playful, eating snacks, smiling, and interactive. I was reassured by her exam but offered to report.
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt was given bivalent instead of dose 2 of the primary series.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deafness, Idiopathic environmental intolerance, Tinnitus
Clinical narrative: Hearing loss, Tinnitus, and Electrical hypersensitivity (EHS), which feels like my body is trying to connect to some mainframe computer, or non-grounded wires.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given an expired dose of medication. Patient did not have any adverse reactions to the dose. Patient and mother are aware that this happened and that the patient will need to come back for another vaccine.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse effect was reported. Previous lot number AS7164B was taken for a Bivalent dose at check-in.
Age: 11.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia
Clinical narrative: PATIENT'S MOTHER REPORTED 100.8 FEVER STARTED AT 12 NOON. THE PATIENT WAS ADVISED TO PROVIDE TYLENOL AS PER THE DOSAGE INSTRUCTION ON THE BOX. IF THE FEVER GOES MORE THAN 101.4 OR SYMPTOMPS GETS WORST SHOULD VISIT DR. OFFICE.
Age: 19.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Vaccine card improperly marked and did not indicate a bivalent covid vaccine was given.  Patient received 2 doses of Pfizer bivalent covid vaccine.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Dyspnoea, Fraction of inspired oxygen
Clinical narrative: pt had a positive COVID test at Center for Rehab on 6/28/22; pt brought to hospital on 7/6/22 with worsening SOB secondary to COVID pneumonia; worsening respiratory requirements; 100% FiO2 via mask; ICU; worsening renal function; pt's condition continued to deteriorate; poor prognosis; steroids and ABX given; family requested comfort care; pt passed away  in the hospital
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Intensive care, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: pt had a positive COVID test at Center for Rehab on 6/28/22; pt brought to hospital on 7/6/22 with worsening SOB secondary to COVID pneumonia; worsening respiratory requirements; 100% FiO2 via mask; ICU; worsening renal function; pt's condition continued to deteriorate; poor prognosis; steroids and ABX given; family requested comfort care; pt passed away  in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Asthenia, Behaviour disorder, Bladder catheterisation, COVID-19
Clinical narrative: Discharge Provider: PRIVATE MD Primary Care Provider: None Physician, DO Admission Date: 12/1/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/1/2022 PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus detected [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt. is a 78 y.o. male with past medical history significant for essential hypertension, coronary artery disease, and dementia. Pt. presented from Medical Facility with worsening weakness and ground level fall. He was reportedly declining for the past six months, but in the last 3 to 4 days prior to arrival developed increased confusion and new agitation. Vitals were stable on room air. All imaging negative for acute traumatic injuries including CT head. Labs found to be COVID positive. Patient was admitted with COVID-19 infection, generalized weakness and encephalopathy with agitation in setting of underlying dementia. Chest x-ray showed no acute abnormalities. Patient remained on room air since admission thus did not receive decadron nor remdesivir. He developed urinary retention requiring straight catheterization and  urology was consulted.  He was started on flomax and recommended intermittent straight catheterization if PVR > 400.  Urinary retention did improve but still requiring straight catheterization on occasion. Will follow up with urology outpatient. Psychiatry was consulted due to agitation and changed Geodon to nightly Zyprexa with prn Zyprexa for agitation. Urinalysis and culture obtained due to leukocytosis and resulted with Klebsiella and Enterococcus. He was started on IV Unasyn based on susceptibilities and transitioned to PO Augmentin 875-125 mg BID for total of 7 days that was completed inpatient. Throughout admission, patient's orientation, memory and behavior fluctuated but overall improved. Zyprexa was changed to risperdone due to fatigue throughout the day. Patient improved back to his baseline. PT/OT recommended home PT. He will follow up with his PCP outpatient. Pt. is discharging in improved and stable condition
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Computerised tomogram head normal, Condition aggravated, Confusional state, Culture positive
Clinical narrative: Discharge Provider: PRIVATE MD Primary Care Provider: None Physician, DO Admission Date: 12/1/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/1/2022 PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus detected [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt. is a 78 y.o. male with past medical history significant for essential hypertension, coronary artery disease, and dementia. Pt. presented from Medical Facility with worsening weakness and ground level fall. He was reportedly declining for the past six months, but in the last 3 to 4 days prior to arrival developed increased confusion and new agitation. Vitals were stable on room air. All imaging negative for acute traumatic injuries including CT head. Labs found to be COVID positive. Patient was admitted with COVID-19 infection, generalized weakness and encephalopathy with agitation in setting of underlying dementia. Chest x-ray showed no acute abnormalities. Patient remained on room air since admission thus did not receive decadron nor remdesivir. He developed urinary retention requiring straight catheterization and  urology was consulted.  He was started on flomax and recommended intermittent straight catheterization if PVR > 400.  Urinary retention did improve but still requiring straight catheterization on occasion. Will follow up with urology outpatient. Psychiatry was consulted due to agitation and changed Geodon to nightly Zyprexa with prn Zyprexa for agitation. Urinalysis and culture obtained due to leukocytosis and resulted with Klebsiella and Enterococcus. He was started on IV Unasyn based on susceptibilities and transitioned to PO Augmentin 875-125 mg BID for total of 7 days that was completed inpatient. Throughout admission, patient's orientation, memory and behavior fluctuated but overall improved. Zyprexa was changed to risperdone due to fatigue throughout the day. Patient improved back to his baseline. PT/OT recommended home PT. He will follow up with his PCP outpatient. Pt. is discharging in improved and stable condition
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Dementia, Disorientation, Encephalopathy, Enterococcus test positive, Fall
Clinical narrative: Discharge Provider: PRIVATE MD Primary Care Provider: None Physician, DO Admission Date: 12/1/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/1/2022 PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus detected [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt. is a 78 y.o. male with past medical history significant for essential hypertension, coronary artery disease, and dementia. Pt. presented from Medical Facility with worsening weakness and ground level fall. He was reportedly declining for the past six months, but in the last 3 to 4 days prior to arrival developed increased confusion and new agitation. Vitals were stable on room air. All imaging negative for acute traumatic injuries including CT head. Labs found to be COVID positive. Patient was admitted with COVID-19 infection, generalized weakness and encephalopathy with agitation in setting of underlying dementia. Chest x-ray showed no acute abnormalities. Patient remained on room air since admission thus did not receive decadron nor remdesivir. He developed urinary retention requiring straight catheterization and  urology was consulted.  He was started on flomax and recommended intermittent straight catheterization if PVR > 400.  Urinary retention did improve but still requiring straight catheterization on occasion. Will follow up with urology outpatient. Psychiatry was consulted due to agitation and changed Geodon to nightly Zyprexa with prn Zyprexa for agitation. Urinalysis and culture obtained due to leukocytosis and resulted with Klebsiella and Enterococcus. He was started on IV Unasyn based on susceptibilities and transitioned to PO Augmentin 875-125 mg BID for total of 7 days that was completed inpatient. Throughout admission, patient's orientation, memory and behavior fluctuated but overall improved. Zyprexa was changed to risperdone due to fatigue throughout the day. Patient improved back to his baseline. PT/OT recommended home PT. He will follow up with his PCP outpatient. Pt. is discharging in improved and stable condition
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Imaging procedure, Klebsiella test positive, Laboratory test abnormal, Leukocytosis
Clinical narrative: Discharge Provider: PRIVATE MD Primary Care Provider: None Physician, DO Admission Date: 12/1/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/1/2022 PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus detected [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt. is a 78 y.o. male with past medical history significant for essential hypertension, coronary artery disease, and dementia. Pt. presented from Medical Facility with worsening weakness and ground level fall. He was reportedly declining for the past six months, but in the last 3 to 4 days prior to arrival developed increased confusion and new agitation. Vitals were stable on room air. All imaging negative for acute traumatic injuries including CT head. Labs found to be COVID positive. Patient was admitted with COVID-19 infection, generalized weakness and encephalopathy with agitation in setting of underlying dementia. Chest x-ray showed no acute abnormalities. Patient remained on room air since admission thus did not receive decadron nor remdesivir. He developed urinary retention requiring straight catheterization and  urology was consulted.  He was started on flomax and recommended intermittent straight catheterization if PVR > 400.  Urinary retention did improve but still requiring straight catheterization on occasion. Will follow up with urology outpatient. Psychiatry was consulted due to agitation and changed Geodon to nightly Zyprexa with prn Zyprexa for agitation. Urinalysis and culture obtained due to leukocytosis and resulted with Klebsiella and Enterococcus. He was started on IV Unasyn based on susceptibilities and transitioned to PO Augmentin 875-125 mg BID for total of 7 days that was completed inpatient. Throughout admission, patient's orientation, memory and behavior fluctuated but overall improved. Zyprexa was changed to risperdone due to fatigue throughout the day. Patient improved back to his baseline. PT/OT recommended home PT. He will follow up with his PCP outpatient. Pt. is discharging in improved and stable condition
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Memory impairment, SARS-CoV-2 test positive, Urinary retention, Urine analysis abnormal
Clinical narrative: Discharge Provider: PRIVATE MD Primary Care Provider: None Physician, DO Admission Date: 12/1/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/1/2022 PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus detected [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt. is a 78 y.o. male with past medical history significant for essential hypertension, coronary artery disease, and dementia. Pt. presented from Medical Facility with worsening weakness and ground level fall. He was reportedly declining for the past six months, but in the last 3 to 4 days prior to arrival developed increased confusion and new agitation. Vitals were stable on room air. All imaging negative for acute traumatic injuries including CT head. Labs found to be COVID positive. Patient was admitted with COVID-19 infection, generalized weakness and encephalopathy with agitation in setting of underlying dementia. Chest x-ray showed no acute abnormalities. Patient remained on room air since admission thus did not receive decadron nor remdesivir. He developed urinary retention requiring straight catheterization and  urology was consulted.  He was started on flomax and recommended intermittent straight catheterization if PVR > 400.  Urinary retention did improve but still requiring straight catheterization on occasion. Will follow up with urology outpatient. Psychiatry was consulted due to agitation and changed Geodon to nightly Zyprexa with prn Zyprexa for agitation. Urinalysis and culture obtained due to leukocytosis and resulted with Klebsiella and Enterococcus. He was started on IV Unasyn based on susceptibilities and transitioned to PO Augmentin 875-125 mg BID for total of 7 days that was completed inpatient. Throughout admission, patient's orientation, memory and behavior fluctuated but overall improved. Zyprexa was changed to risperdone due to fatigue throughout the day. Patient improved back to his baseline. PT/OT recommended home PT. He will follow up with his PCP outpatient. Pt. is discharging in improved and stable condition
Age: 16.0
Sex: M
Vaccine: FLU4, MENB, MENB
Symptoms: Extra dose administered, No adverse event
Clinical narrative: On 12/6/22, patient received 1 dose of Trumenba and 1 dose of Bexsero, but he should have only received one or the other. There have been no known adverse reactions.
Age: 34.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bronchitis, COVID-19, Chest discomfort, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: 12/12/2022 Started about 6:30 in the evening pinching in the throat. Initially thought it was acid reflux. Deep in throat, about collarbone level. Got up about 4 AM and took a lansoprazole and went back to bed. On 12/13 I woke up with a headache above my eyes and nothing I took could get rid of the headache. I also started getting congested and having body aches. 12/14 I tested with an at home rapid COVID-19 test, this was positive. I had a social gathering the week earlier, 12/9 and 12/10 I had an exposure to Covid. On 12/14 Tele-visit with doctor. Doctor recommended treating the symptoms. I took MUCINEX to help treat the symptoms along with TYLENOL. 12/16 I started experiencing tightness in chest with a pain on the right side. I had difficulty breathing and felt like I was getting bronchitis. I had another tele-visit with doctor who prescribed ZITHROMAX. Symptoms improved considerably, with just stuffiness and at time of reporting.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Nasal congestion, Pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: 12/12/2022 Started about 6:30 in the evening pinching in the throat. Initially thought it was acid reflux. Deep in throat, about collarbone level. Got up about 4 AM and took a lansoprazole and went back to bed. On 12/13 I woke up with a headache above my eyes and nothing I took could get rid of the headache. I also started getting congested and having body aches. 12/14 I tested with an at home rapid COVID-19 test, this was positive. I had a social gathering the week earlier, 12/9 and 12/10 I had an exposure to Covid. On 12/14 Tele-visit with doctor. Doctor recommended treating the symptoms. I took MUCINEX to help treat the symptoms along with TYLENOL. 12/16 I started experiencing tightness in chest with a pain on the right side. I had difficulty breathing and felt like I was getting bronchitis. I had another tele-visit with doctor who prescribed ZITHROMAX. Symptoms improved considerably, with just stuffiness and at time of reporting.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Throat irritation
Clinical narrative: 12/12/2022 Started about 6:30 in the evening pinching in the throat. Initially thought it was acid reflux. Deep in throat, about collarbone level. Got up about 4 AM and took a lansoprazole and went back to bed. On 12/13 I woke up with a headache above my eyes and nothing I took could get rid of the headache. I also started getting congested and having body aches. 12/14 I tested with an at home rapid COVID-19 test, this was positive. I had a social gathering the week earlier, 12/9 and 12/10 I had an exposure to Covid. On 12/14 Tele-visit with doctor. Doctor recommended treating the symptoms. I took MUCINEX to help treat the symptoms along with TYLENOL. 12/16 I started experiencing tightness in chest with a pain on the right side. I had difficulty breathing and felt like I was getting bronchitis. I had another tele-visit with doctor who prescribed ZITHROMAX. Symptoms improved considerably, with just stuffiness and at time of reporting.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Blood pressure increased, Heart rate increased, Lip swelling, Peripheral swelling, Swelling
Clinical narrative: Face, neck, lips, arm swollen, increased heart rate and increased blood pressure
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Swelling face
Clinical narrative: Face, neck, lips, arm swollen, increased heart rate and increased blood pressure
Age: 76.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: The patient recalled that she had been previously vaccinated after receiving her flu shot. When questioned before ,during the initial interview with the technician, she indicated that she had not been vaccinated for some time.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Feeling abnormal, SARS-CoV-2 test positive
Clinical narrative: The exposures were Nov 30th at a gathering about 16 people total came up with a positive reading from this. I had postnasal drip and a scratchy throat on Dec 2. I played a 3-hour concert that night and standing so I wasn't feeling so bad. The next day I started feeling fatigue and with a call from a fellow member and they said they tested positive. I felt like I had a minor cold at first just very tired. I tested myself and found that I was positive as well. December 4, I had a telehealth visit from my doctor and received a prescription for PAXLOVID. The medication helped so much by the second day I could tell that I was starting to improve. The medication had a really bad after taste, but I was told that it's normal to have a bad after taste.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Throat irritation, Upper-airway cough syndrome
Clinical narrative: The exposures were Nov 30th at a gathering about 16 people total came up with a positive reading from this. I had postnasal drip and a scratchy throat on Dec 2. I played a 3-hour concert that night and standing so I wasn't feeling so bad. The next day I started feeling fatigue and with a call from a fellow member and they said they tested positive. I felt like I had a minor cold at first just very tired. I tested myself and found that I was positive as well. December 4, I had a telehealth visit from my doctor and received a prescription for PAXLOVID. The medication helped so much by the second day I could tell that I was starting to improve. The medication had a really bad after taste, but I was told that it's normal to have a bad after taste.
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Systemic lupus erythematosus
Clinical narrative: LUPUS
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ear discomfort, Hypoacusis
Clinical narrative: Approximately five weeks after receiving the vaccine I noticed my right ear is closed with diminished hearing, it remains blocked as of the date of this report. I took ten days of prescription ear drops Neomycin Polymyxin B Sulfate  Hydrocortisone   11/18/2022-11/27/2022 without improvement, I also took Afrin with no results. On the thirteenth of December 2022 I was tested and it was noted I have diminished hearing and no vibration in my right eardrum.
Age: 52.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Anaphylactic reaction, Angioedema, Dysphagia, Lip swelling, Oral discomfort
Clinical narrative: Patient presented to emergency department with complaint of bottom lip and cheek swelling, burning on lips, feeling itchy, and difficulty swallowing. No difficulty breathing. Patient was diagnosed with angioedema/anaphylaxis. Patient was treated with IV dexamethasone 4 mg every 8 hours.  IV famotidine 20 mg twice daily.  IV diphenhydramine 25 mg every 8 hours x3 doses. and IV fluids (lactated ringers). Patient improved over the course of about 12 hours.
Age: 52.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Pruritus, Swelling face
Clinical narrative: Patient presented to emergency department with complaint of bottom lip and cheek swelling, burning on lips, feeling itchy, and difficulty swallowing. No difficulty breathing. Patient was diagnosed with angioedema/anaphylaxis. Patient was treated with IV dexamethasone 4 mg every 8 hours.  IV famotidine 20 mg twice daily.  IV diphenhydramine 25 mg every 8 hours x3 doses. and IV fluids (lactated ringers). Patient improved over the course of about 12 hours.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Haemoptysis, Headache, Pneumonia, Pyrexia
Clinical narrative: On November 23, 2022, I woke up with a lot of congestion, fever and headache.  On December 7th, I started coughing up blood when I went to the urgent care.  I was diagnosed with pneumonia and given Doxycycline.  All of my symptoms have gone away but I still have the cough.  Not a productive cough from the chest.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion
Clinical narrative: On November 23, 2022, I woke up with a lot of congestion, fever and headache.  On December 7th, I started coughing up blood when I went to the urgent care.  I was diagnosed with pneumonia and given Doxycycline.  All of my symptoms have gone away but I still have the cough.  Not a productive cough from the chest.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Diarrhoea, Dyspnoea
Clinical narrative: MODERNA COVID VACCINE #3 GIVEN 5/28/22, LOT #058A22-2A; pt admitted to hospital with worsening SOB; hypoxia; c/o diarrhea and generalized weakness; 1 wk ago pt dx with COVID, started on Paxlovid, completed the course; diarrhea has continued; placed in ICU; required vasopressors, ABX, steroids, BiPAP; didn't respond to tx in ICU; pt found passed away in the hospital
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Intensive care, Positive airway pressure therapy
Clinical narrative: MODERNA COVID VACCINE #3 GIVEN 5/28/22, LOT #058A22-2A; pt admitted to hospital with worsening SOB; hypoxia; c/o diarrhea and generalized weakness; 1 wk ago pt dx with COVID, started on Paxlovid, completed the course; diarrhea has continued; placed in ICU; required vasopressors, ABX, steroids, BiPAP; didn't respond to tx in ICU; pt found passed away in the hospital
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Erythema, Pain, Swelling
Clinical narrative: erythema, swelling and pain
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Computerised tomogram normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/4/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/4/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 infection Ground-glass opacity secondary to COVID-19 COPD     HOSPITAL COURSE: 58 y/o male with hx of COPD,who was admitted for acute hypoxic respiratory failure 2/2 COVID pneumonia.  He has completed 10 day course of decadron.  He was not given remdesivir given length of time since onset of symptoms.     Initially patient required 5L O2 via Nc, but were able to titrate down to 2 L of oxygen at all times.   Patient is homeless and stays at shelter and was discharged in stable condition.   He will continue to follow-up with PCP and counseled about tobacco cessation
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Emphysema, Face injury
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/4/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/4/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 infection Ground-glass opacity secondary to COVID-19 COPD     HOSPITAL COURSE: 58 y/o male with hx of COPD,who was admitted for acute hypoxic respiratory failure 2/2 COVID pneumonia.  He has completed 10 day course of decadron.  He was not given remdesivir given length of time since onset of symptoms.     Initially patient required 5L O2 via Nc, but were able to titrate down to 2 L of oxygen at all times.   Patient is homeless and stays at shelter and was discharged in stable condition.   He will continue to follow-up with PCP and counseled about tobacco cessation
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Facial bones fracture, Fall, Head injury, Homeless, Hypoxia
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/4/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/4/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 infection Ground-glass opacity secondary to COVID-19 COPD     HOSPITAL COURSE: 58 y/o male with hx of COPD,who was admitted for acute hypoxic respiratory failure 2/2 COVID pneumonia.  He has completed 10 day course of decadron.  He was not given remdesivir given length of time since onset of symptoms.     Initially patient required 5L O2 via Nc, but were able to titrate down to 2 L of oxygen at all times.   Patient is homeless and stays at shelter and was discharged in stable condition.   He will continue to follow-up with PCP and counseled about tobacco cessation
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza virus test negative, Injury, Lung opacity, Pneumonia, Respiratory syncytial virus test negative
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/4/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/4/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 infection Ground-glass opacity secondary to COVID-19 COPD     HOSPITAL COURSE: 58 y/o male with hx of COPD,who was admitted for acute hypoxic respiratory failure 2/2 COVID pneumonia.  He has completed 10 day course of decadron.  He was not given remdesivir given length of time since onset of symptoms.     Initially patient required 5L O2 via Nc, but were able to titrate down to 2 L of oxygen at all times.   Patient is homeless and stays at shelter and was discharged in stable condition.   He will continue to follow-up with PCP and counseled about tobacco cessation
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive, Skin laceration, Suture insertion, Victim of crime
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/4/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/4/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 infection Ground-glass opacity secondary to COVID-19 COPD     HOSPITAL COURSE: 58 y/o male with hx of COPD,who was admitted for acute hypoxic respiratory failure 2/2 COVID pneumonia.  He has completed 10 day course of decadron.  He was not given remdesivir given length of time since onset of symptoms.     Initially patient required 5L O2 via Nc, but were able to titrate down to 2 L of oxygen at all times.   Patient is homeless and stays at shelter and was discharged in stable condition.   He will continue to follow-up with PCP and counseled about tobacco cessation
Age: 36.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 37.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Loss of consciousness, Malaise, Syncope
Clinical narrative: Patient received both the flu vaccine and COVID booster at 0915 and sat in the lobby for the 15 minute waiting period. At 0930, the patient came to the counter of the pharmacy and stated she did not feel well. The pharmacist and myself (pharmacy intern) approached the patient, grabbed both arms and gently lowered her to the ground as she had fainted. The pharmacy is within a healthcare facility and urgent care staff were alerted and attended to the patient. The patient was unconscious for less than a minute and recovered quickly. Urgent care staff included two RNs and one MD. Patient was evaluated in the lobby without a office visit and given snack and juice and recovered quickly. After she woke up, she stated she was anxious and didn't eat much prior to her vaccine appointment. She left the health care facility feeling well.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Influenza virus test negative
Clinical narrative: On 12/03/2022 I went to an urgent care. It hit me really fast and hard. It started early in the morning, unable to sleep, body aches, fatigue and congestion. The first two days were very bad. The third day I lost my smell and taste. They did not swab me correctly on 12/03/2022 so I tested negative. I then tested positive on 12/06/22.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Respiratory tract congestion, SARS-CoV-2 test positive, Sleep disorder, Streptococcus test negative
Clinical narrative: On 12/03/2022 I went to an urgent care. It hit me really fast and hard. It started early in the morning, unable to sleep, body aches, fatigue and congestion. The first two days were very bad. The third day I lost my smell and taste. They did not swab me correctly on 12/03/2022 so I tested negative. I then tested positive on 12/06/22.
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest discomfort, Chest pain, Vertigo
Clinical narrative: Patient felt of having a vertigo a few minutes after the vaccination.  Patient was asked to relax in the chair and was offered drinking water.  After the vertigo symptoms went away,  patient went home.  She called back around 30 minutes later and mentioned having "chest pressure / tightness".  Patient was asked to go the Emergency Room.  Patient did not response to our follow-up phone calls.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Influenza, Influenza virus test positive, Malaise, Nasal congestion
Clinical narrative: He tested positive for the flu on 11/26/22. He was sick for about a week with a fever, cough, congestion, and body aches. He was not prescribed medications, but he was taking over-the-counter MOTRIN and TYLENOL. He is feeling better, but still has a lingering cough and stuffy nose.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: He tested positive for the flu on 11/26/22. He was sick for about a week with a fever, cough, congestion, and body aches. He was not prescribed medications, but he was taking over-the-counter MOTRIN and TYLENOL. He is feeling better, but still has a lingering cough and stuffy nose.
Age: 26.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Extra dose administered
Clinical narrative: Patient came in for flu vaccine. Upon documentation discovered that patient had received a flu shot on 09/21/22. PCP and patient called.
Age: 34.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vaginal haemorrhage
Clinical narrative: Non-menstrual vaginal bleeding, bright red (no clots). This has lasted for 6 days. No associated pain.
Age: 70.0
Sex: M
Vaccine: FLU4
Symptoms: Computerised tomogram head, Computerised tomogram spine, Fall, Full blood count, Gait inability
Clinical narrative: Patient admitted 12/18/22 stating he had a flu shot 6 days prior (attempted to confirm but no flu vaccine information available in system). He was complaining of weakness to both lower extremities that began shortly after receiving the flu vaccine and then began to move into his arms as well to the point that was unable to walk and fell multiple times. Initially seen in ER and then admitted as an inpatient with initial diagnosis of Guillian-Barre syndrome. Neurology was consulted and saw 12/19 and concurred with this diagnosis and ordered IgG infusion (Privigen) 40Gm daily x 5 doses.
Age: 70.0
Sex: M
Vaccine: FLU4
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy, Laboratory test, Magnetic resonance imaging head, Muscular weakness
Clinical narrative: Patient admitted 12/18/22 stating he had a flu shot 6 days prior (attempted to confirm but no flu vaccine information available in system). He was complaining of weakness to both lower extremities that began shortly after receiving the flu vaccine and then began to move into his arms as well to the point that was unable to walk and fell multiple times. Initially seen in ER and then admitted as an inpatient with initial diagnosis of Guillian-Barre syndrome. Neurology was consulted and saw 12/19 and concurred with this diagnosis and ordered IgG infusion (Privigen) 40Gm daily x 5 doses.
Age: 70.0
Sex: M
Vaccine: FLU4
Symptoms: Urine analysis, X-ray limb
Clinical narrative: Patient admitted 12/18/22 stating he had a flu shot 6 days prior (attempted to confirm but no flu vaccine information available in system). He was complaining of weakness to both lower extremities that began shortly after receiving the flu vaccine and then began to move into his arms as well to the point that was unable to walk and fell multiple times. Initially seen in ER and then admitted as an inpatient with initial diagnosis of Guillian-Barre syndrome. Neurology was consulted and saw 12/19 and concurred with this diagnosis and ordered IgG infusion (Privigen) 40Gm daily x 5 doses.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blindness, Blood pressure decreased, Cognitive disorder, Condition aggravated
Clinical narrative: The continuing conditions are inability to be upright, and cognitive issue and nausea, drops in blood pressure and also had constant migraine, which still continues. I had an MRI on May 21, 2022. Orthostatic tachycardiac, new cognitive conditions and a lot of weakness, and fatigue. Although I can sit upright a year later, I need to have my legs upright. I am now a full-time wheelchair user. Started optic neuritis approximately on August 13, 2022 and I had lost my vision for about 2 months, which has mostly recovered but not fully.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Magnetic resonance imaging, Migraine, Nausea, Optic neuritis
Clinical narrative: The continuing conditions are inability to be upright, and cognitive issue and nausea, drops in blood pressure and also had constant migraine, which still continues. I had an MRI on May 21, 2022. Orthostatic tachycardiac, new cognitive conditions and a lot of weakness, and fatigue. Although I can sit upright a year later, I need to have my legs upright. I am now a full-time wheelchair user. Started optic neuritis approximately on August 13, 2022 and I had lost my vision for about 2 months, which has mostly recovered but not fully.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Postural orthostatic tachycardia syndrome, Posture abnormal, Wheelchair user
Clinical narrative: The continuing conditions are inability to be upright, and cognitive issue and nausea, drops in blood pressure and also had constant migraine, which still continues. I had an MRI on May 21, 2022. Orthostatic tachycardiac, new cognitive conditions and a lot of weakness, and fatigue. Although I can sit upright a year later, I need to have my legs upright. I am now a full-time wheelchair user. Started optic neuritis approximately on August 13, 2022 and I had lost my vision for about 2 months, which has mostly recovered but not fully.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Fatigue, Headache, Malaise
Clinical narrative: I started feeling ill on 11/19/2022 I had a sore throat; headache; extreme fatigue; low grade fever 99.1and body aches. I completed a course of PAXLOVID. I have recovered but I do have a lingering cough.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I started feeling ill on 11/19/2022 I had a sore throat; headache; extreme fatigue; low grade fever 99.1and body aches. I completed a course of PAXLOVID. I have recovered but I do have a lingering cough.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site discolouration, Injection site pain, Injection site reaction, Skin wound
Clinical narrative: Area of injection site started to hurt about 15 min after vaccine administration.  12/17/22, later in the evening noticed bruising around the injection site area.  Skin appears slightly broken where needle entered arm/injection site.  Patient reported to pharmacy in person 12/18/22 at 2:30 pm.  Observed bruise that was approximately 1.5 to 2 inches in diameter, pale blue bruising/discoloration, with darker/more purple areas that radiated out from injection site.  No swelling or inflammation.  Skin slightly broken where needle entered arm.  Patient said that she felt normal.  Denies fever, denies body aches.  Patient did state that it was healing and improved from how it looked the previous day.  Recommended to call her primary care physician on Monday 12/19/22 and to keep an eye on it.  Advised to visit physician if symptoms worsened.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, General physical health deterioration, Renal failure, SARS-CoV-2 test positive
Clinical narrative: during hospitalization in August 2021, pt tested positive for COVID; pt in hospital; 9/16 - 10/1/21 pt hospitalized for renal failure; poor prognosis; pt's condition worsened; family refused SNF again; wished to take pt home on hospice; dc'd to home where pt passed away 9 days later
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Biopsy skin abnormal, Micrographic skin surgery, Neoplasm skin, Papule
Clinical narrative: I had a papule on my right lateral nostril. It was removed once and biopsied twice. It was excised via Mohs surgery on November 21, 2022.
Age: 85.0
Sex: F
Vaccine: MNQ
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient needed Shingrix vaccine and was given Menveo by mistake.  Patient suffered no ill effects from receiving this vaccine.  Will vaccinate with Shigrix ASAP.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 12/19/22
Age: 8.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: I gave the monovalent instead of the bivalent dose to this patient.  There was not adverse reaction.   I just need to give the bivalent dose to this patient now.
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Fatigue, Influenza, Influenza virus test positive, Nasal congestion
Clinical narrative: She tested positive for the flu on 11/26/22. She had a fever, cough, stuffy nose, and fatigue. This lasted for about 2 weeks. She was not prescribed medications, but she took over-the-counter MOTRIN and TYLENOL. She still has a little bit of a cough and stuffy nose, but it has improved tremendously.
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia
Clinical narrative: She tested positive for the flu on 11/26/22. She had a fever, cough, stuffy nose, and fatigue. This lasted for about 2 weeks. She was not prescribed medications, but she took over-the-counter MOTRIN and TYLENOL. She still has a little bit of a cough and stuffy nose, but it has improved tremendously.
Age: 2.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Death
Clinical narrative: Death after receiving both COVID and annual Influenza vaccines
Age: 39.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 86.0
Sex: M
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: Patient needed Shingrix vaccination and received Menveo by mistake, no ill effects were noted from this vaccination.  Shingrix will be given ASAP.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: Primary series administered without any adverse effects. This booster dose resulted in high fever (103.5F), shivers, extreme sweating, severe headache, which persisted until the third day after the onset. Hydration maintained; acetominophen 1g administered TID for the duration of the fever and headache..
Age: 43.0
Sex: M
Vaccine: FLU4
Symptoms: Influenza, Laboratory test
Clinical narrative: Contracted flu 2022 Dec 19 Mon
Age: 11.0
Sex: F
Vaccine: FLU4, MNQ, TDAP
Symptoms: Syncope
Clinical narrative: syncope, vitals taken and were stable, and observed 30 min
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Expired product administered
Clinical narrative: Client given expired Kinrix . Expiration date 9/30/22. No treatment needed. Client returned for revaccination on 11/1/2022.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Influenza A virus test positive, Productive cough
Clinical narrative: Symptoms began with a fever as high of 102 that lasted for about 2 days, and I tested positive for COVID-19.  On the second day my fever broke.  I had some productive coughing and congestion.  But I tested positive a second time on September 9, 2022.  I lost my sense of taste and smell the first time I tested positive.  This symptom lasted for about 3-4 weeks.  I also tested positive for Influenza A on November 15, 2022.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Symptoms began with a fever as high of 102 that lasted for about 2 days, and I tested positive for COVID-19.  On the second day my fever broke.  I had some productive coughing and congestion.  But I tested positive a second time on September 9, 2022.  I lost my sense of taste and smell the first time I tested positive.  This symptom lasted for about 3-4 weeks.  I also tested positive for Influenza A on November 15, 2022.
Age: 67.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: COVID-19, Cough, Drainage, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I was congested in upper respiratory system, fever at 99 degrees, cough, drainage.
Age: 67.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Upper respiratory tract congestion
Clinical narrative: I was congested in upper respiratory system, fever at 99 degrees, cough, drainage.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Angiogram cerebral, Arteriogram carotid, Asthenia, Dysarthria, Dyskinesia
Clinical narrative: Taken by ambulance from home to hospital. Husband reports symptoms to be slurred speech, overall weakness in body, thrashing around in bed. Approx. 6am on 11-18-22. Admitted to hospital for 1 day and did testing. Diagnosis was Ischemic Stroke. Follow up with Primary physician and other specialists.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Electrocardiogram, Ischaemic stroke, Laboratory test, Metabolic function test, Scan with contrast
Clinical narrative: Taken by ambulance from home to hospital. Husband reports symptoms to be slurred speech, overall weakness in body, thrashing around in bed. Approx. 6am on 11-18-22. Admitted to hospital for 1 day and did testing. Diagnosis was Ischemic Stroke. Follow up with Primary physician and other specialists.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Discharge, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: symptoms: runny nose, drainage, coughing started 12/09/22.  worsened on 12/10.  Did rapid Covid test 12/11/22 @ 8:00AM.  Positive.  Called Dr's office after-hours nurse line.  Reported symptoms and + Covid test.  Because of mild symptoms, directed to isolate, mask, avoid contact, maintain social distancing.  Treat symptoms (sudafed, mucinex) and call back in 24 hrs.  Symptoms improved and was removed from quarantine 12/14.
Age: 49.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Acne, Hyperhidrosis, Injection site erythema, Injection site rash, Injection site reaction
Clinical narrative: Rash at injection site and around it about 2 inches in diameter as well as a red pimple looking thing where injection was given. This appeared shortly after the injection was given and is still there three days later.  Approx 24 hours later, i started feeling achy all over and the night of 17th, woke up middle of the night with a slight fever and drenched in sweat all over. It was mostly gone when I woke up at 6am to go to work , it was mostly gone and dissipated sometime that morning.
Age: 49.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Pain, Pyrexia, Sleep disorder
Clinical narrative: Rash at injection site and around it about 2 inches in diameter as well as a red pimple looking thing where injection was given. This appeared shortly after the injection was given and is still there three days later.  Approx 24 hours later, i started feeling achy all over and the night of 17th, woke up middle of the night with a slight fever and drenched in sweat all over. It was mostly gone when I woke up at 6am to go to work , it was mostly gone and dissipated sometime that morning.
Age: 1.5
Sex: M
Vaccine: COVID19, DTAP
Symptoms: Unevaluable event
Clinical narrative: UNKNOWN
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.